➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Mallinckrodt
Colorcon
Harvard Business School
Moodys

Last Updated: July 28, 2021

DrugPatentWatch Database Preview

RAMIPRIL Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Ramipril, and when can generic versions of Ramipril launch?

Ramipril is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Apotex, Aurobindo Pharma Ltd, Chartwell Molecular, Cipla, Dr Reddys Labs Ltd, Hikma, Lupin, Ranbaxy Labs Ltd, Teva Pharms, Watson Labs, Yaopharma Co Ltd, Zydus Pharms Usa, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in seventeen NDAs.

The generic ingredient in RAMIPRIL is ramipril. There are nineteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ramipril profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ramipril

A generic version of RAMIPRIL was approved as ramipril by WATSON LABS on October 24th, 2005.

  Free Forever Trial

Paragraph IV (Patent) Challenges for RAMIPRIL
Tradename Dosage Ingredient NDA Submissiondate
ALTACE CAPSULE;ORAL ramipril 019901

US Patents and Regulatory Information for RAMIPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms RAMIPRIL ramipril CAPSULE;ORAL 077470-003 Jun 18, 2008 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Hikma RAMIPRIL ramipril CAPSULE;ORAL 077900-004 Jun 18, 2008 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Yaopharma Co Ltd RAMIPRIL ramipril CAPSULE;ORAL 077514-003 Jun 18, 2008 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Mylan Pharms Inc RAMIPRIL ramipril TABLET;ORAL 090650-002 Jun 30, 2011 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Mallinckrodt
Colorcon
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.